Revvity Omics Inc public contracts.

Revvity Omics Inc has won 6 public contracts between 2022 and 2025 from 3 public buyers in United States. Its most frequent buyer is Department of Defense - Department of the Army (4 awards). Published values total $641,521 across 6 awards.

Start bidding All awards in United States

6Contracts won

3Public buyers

1Country

Sep 2025Latest award

Latest contracts won

Contract award

Awarded by Department of Defense - Defense Health Agency · United States · $42,993

29 Sep 2025Awarded

Newborn Screening Testing Services

Awarded by Department of Defense - Department of the Army · United States · $324,512

1 Oct 2024Awarded

Newborn Screening Testing Services for Bdaach, Korea. FY24 Task Order for the Base Period, 29 Sep 2024 - 28 Sep 2025.

Awarded by Department of Defense - Department of the Army · United States · $40,946

29 Sep 2024Awarded

Newborn Screening Testing Services for Bdaach, Korea - Task Order for Option Iv. Pop Is 29 September 2023 Through 28 September 2024.

Awarded by Department of Defense - Department of the Army · United States · $44,717

29 Sep 2023Awarded

Newborn Genetic Screening Services

Awarded by Department of Defense - Department of the Air Force · United States · $112,544

10 Aug 2023Awarded

Newborn Screen Testing Services

Awarded by Department of Defense - Department of the Army · United States · $75,810

1 Sep 2022Awarded

Contracts won by year

from the published records

20221

20232

20242

20251

Published value, by currency

USD · 6 valued

$641,521

From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted.

Bid with askTender

Bidding against Revvity Omics Inc?

askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.

Start bidding See open tenders